108 related articles for article (PubMed ID: 27341380)
1. Xenon elimination kinetics following brief exposure.
Schaefer MS; Piper T; Geyer H; Schneemann J; Neukirchen M; Thevis M; Kienbaum P
Drug Test Anal; 2017 May; 9(5):666-670. PubMed ID: 27341380
[TBL] [Abstract][Full Text] [Related]
2. Measuring xenon in human plasma and blood by gas chromatography/mass spectrometry.
Thevis M; Piper T; Geyer H; Thomas A; Schaefer MS; Kienbaum P; Schänzer W
Rapid Commun Mass Spectrom; 2014 Jul; 28(13):1501-6. PubMed ID: 24861600
[TBL] [Abstract][Full Text] [Related]
3. Urine analysis concerning xenon for doping control purposes.
Thevis M; Piper T; Geyer H; Schaefer MS; Schneemann J; Kienbaum P; Schänzer W
Rapid Commun Mass Spectrom; 2015 Jan; 29(1):61-6. PubMed ID: 25462364
[TBL] [Abstract][Full Text] [Related]
4. Sub-anesthetic Xenon Increases Erythropoietin Levels in Humans: A Randomized Controlled Trial.
Stoppe C; Ney J; Brenke M; Goetzenich A; Emontzpohl C; Schälte G; Grottke O; Moeller M; Rossaint R; Coburn M
Sports Med; 2016 Nov; 46(11):1753-1766. PubMed ID: 26939898
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous detection of xenon and krypton in equine plasma by gas chromatography-tandem mass spectrometry for doping control.
Kwok WH; Choi TL; So PK; Yao ZP; Wan TS
Drug Test Anal; 2017 Feb; 9(2):317-322. PubMed ID: 27001214
[TBL] [Abstract][Full Text] [Related]
6. Xenon detection in human blood: Analytical validation by accuracy profile and identification of critical storage parameters.
Frampas C; Ney J; Coburn M; Augsburger M; Varlet V
J Forensic Leg Med; 2018 Aug; 58():14-19. PubMed ID: 29679839
[TBL] [Abstract][Full Text] [Related]
7. Gas chromatography/mass spectrometry measurement of xenon in gas-loaded liposomes for neuroprotective applications.
Klegerman ME; Moody MR; Hurling JR; Peng T; Huang SL; McPherson DD
Rapid Commun Mass Spectrom; 2017 Jan; 31(1):1-8. PubMed ID: 27689777
[TBL] [Abstract][Full Text] [Related]
8. Arterial and mixed venous xenon blood concentrations in pigs during wash-in of inhalational anaesthesia.
Nalos M; Wachter U; Pittner A; Georgieff M; Radermacher P; Froeba G
Br J Anaesth; 2001 Sep; 87(3):497-8. PubMed ID: 11517138
[TBL] [Abstract][Full Text] [Related]
9. In Vivo Measurement in Pigs of Wash-In Kinetics of Xenon at its Site of Action.
Froeba G; Adolph O
Curr Clin Pharmacol; 2016; 11(4):224-229. PubMed ID: 27554392
[TBL] [Abstract][Full Text] [Related]
10. [Xenon--the ideal anaesthetic agent?].
Bein B; Höcker J; Scholz J
Anasthesiol Intensivmed Notfallmed Schmerzther; 2007 Nov; 42(11):784-91. PubMed ID: 18040933
[TBL] [Abstract][Full Text] [Related]
11. The blood-gas partition coefficient of xenon may be lower than generally accepted.
Goto T; Suwa K; Uezono S; Ichinose F; Uchiyama M; Morita S
Br J Anaesth; 1998 Feb; 80(2):255-6. PubMed ID: 9602599
[TBL] [Abstract][Full Text] [Related]
12. Monitoring 2-phenylethanamine and 2-(3-hydroxyphenyl)acetamide sulfate in doping controls.
Sigmund G; Dib J; Tretzel L; Piper T; Bosse C; Schänzer W; Thevis M
Drug Test Anal; 2015; 7(11-12):1057-62. PubMed ID: 26481102
[TBL] [Abstract][Full Text] [Related]
13. Safety, hemodynamic effects, and detection of acute xenon inhalation: rationale for banning xenon from sport.
Lawley JS; Gatterer H; Dias KA; Howden EJ; Sarma S; Cornwell WK; Hearon CM; Samels M; Everding B; Bruick RK; Hendrix M; Piper T; Thevis M; Levine BD
J Appl Physiol (1985); 2019 Dec; 127(6):1511-1518. PubMed ID: 31414955
[TBL] [Abstract][Full Text] [Related]
14. Ultra high performance liquid chromatography tandem mass spectrometry determination and profiling of prohibited steroids in human biological matrices. A review.
Gosetti F; Mazzucco E; Gennaro MC; Marengo E
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May; 927():22-36. PubMed ID: 23317577
[TBL] [Abstract][Full Text] [Related]
15. Xenon expenditure and nitrogen accumulation in closed-circuit anaesthesia.
Reinelt H; Marx T; Schirmer U; Schmidt M
Anaesthesia; 2001 Apr; 56(4):309-11. PubMed ID: 11284815
[TBL] [Abstract][Full Text] [Related]
16. Analysis of tolvaptan and its metabolites in sports drug testing by high-performance liquid chromatography coupled to tandem mass spectrometry.
Rzeppa S; Viet LN
Drug Test Anal; 2016 Oct; 8(10):1090-1094. PubMed ID: 26768215
[TBL] [Abstract][Full Text] [Related]
17. The quantitative analysis of inhalational anaesthetics in forensic samples by gas chromatography/mass spectrometry/selected ion monitoring.
Maruyama K; Takatsu A; Obata T
Biomed Chromatogr; 1995; 9(4):179-82. PubMed ID: 8520207
[TBL] [Abstract][Full Text] [Related]
18. Mass spectrometric characterization of a biotechnologically produced full-length mechano growth factor (MGF) relevant for doping controls.
Thevis M; Thomas A; Geyer H; Schänzer W
Growth Horm IGF Res; 2014 Dec; 24(6):276-80. PubMed ID: 25466910
[TBL] [Abstract][Full Text] [Related]
19. Determination of sevoflurane and its metabolite hexafluoroisopropanol by direct injection of human plasma into gas chromatography-tandem mass spectrometry.
Kubincová J; Szabóová A; Podolec P; Blaško J; Soják L; Górová R; Addová G; Ostrovský I; Višňovský J; Amann A; Mochalski P; Höfer J; Benzer A; Behúlová D; Kubinec R
J Chromatogr A; 2012 Jan; 1219():173-6. PubMed ID: 22137778
[TBL] [Abstract][Full Text] [Related]
20. Mass spectrometric characterization of a prolyl hydroxylase inhibitor GSK1278863, its bishydroxylated metabolite, and its implementation into routine doping controls.
Thevis M; Milosovich S; Licea-Perez H; Knecht D; Cavalier T; Schänzer W
Drug Test Anal; 2016 Aug; 8(8):858-63. PubMed ID: 26361079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
